- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00747747
Sinuclean's Treatment Of Sinusitis' Symptoms (SToSS)
Safety and Efficacy (for Symptoms Remission) of the Treatment of the Acute Episode of Sinusitis With Ecballium Elaterium (SINUclean DM® Nasal Spray) as Co-adjuvant of the Antibiotic Therapy: Comparative, Prospective, Randomized, Open Study.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The randomized subject with diagnosis of acute episode of sinusitis with symptoms and mucus in the paranasal sinuses, will treat his/her condition with background amoxicillin/clavulanate and with inhalation of Sinuclean or Saline, while the control group will not use any spray for symptom relief. Anti-histaminic, steroidal anti-inflammatory drugs are forbidden. The patient is requested to evaluate his state of symptoms by recording in a diary
- the pain or feeling of facial oppression;
- nasal dripping anterior or posterior;
nasal congestion. SCALE 0 = no symptom
- = mild symptom: clearly perceptible, but easily tolerated
- = moderate symptom: clear awareness of the symptom, that is annoying but tolerable
- = severe: symptom very annoying, difficult to tolerate, interfering with the ordinary life Four measures per day (2 for administration of the therapy - before/after) of which the median will be used; plus an evening measure "retrospective" of the past 12 hours.
If possible it will be assessed the status of paranasal sinuses before and after the treatment with a CT scan.
The treatment intervals is the week. After baseline and start of treatment, are planned two control visit. The subject will complete the study at the first control visit without symptoms. After the second visit, if the symptoms are still present, the subject will complete as a "treatment-failure".
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Lazio
-
Rome, Lazio, Italy, 00168
- University Cattolica del Sacro Cuore
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male or female sex.
- Age > 18 years old.
- Diagnosis of acute episode of sinusitis (in an acute, subacute or chronic background), confirmed with a CT scan image.
- Presence of mucus in para-nasal sinuses.
- Symptoms of facial pain associated to the congestion of the mucosa of the paranasal sinuses for at least three days.
- Written informed consent.
- Expressed intention of compliance with the study requirements.
Exclusion Criteria:
- In case of female subject: ongoing pregnancy or lactating; or condition of fecundity without abstinence.
- Assumption, during the study, of drugs that can interfere with the evaluation of the investigational drug (see Section "Concomitant Therapy")
- Possible necessity of treatment, during the study, with drugs that are not allowed (see section "Concomitant Therapy").
- Clinical conditions (systemic pathologies or other) that can interfere with the assessment of the safety and efficacy of the investigational drug, in example: viral or allergic rhinitis with active secretive symptomatology, presence of visible nasal polyps, diagnosis of immobile cilia syndrome, diseases determining immunodeficiency cystic fibrosis immunocompromission renal insufficiency, dialysis, pathology of other apparatus that, in the opinion of the investigator, necessity of a supplementary antibiotic therapy,due to other pathologies, besides the one standard of the sinusitis.
- Psychical conditions not compatible with the participation to the clinical trial.
- Alcohol abuse or other dependencies on stupefacents
- Smoking during the period of the study
- History of intolerance or allergy to the components of SINUclean DM®
- Surgical or medical intervention that can jeopardize the complete performance of the trial, in the 4 wks preceding the administration of the informed consent
- Planning of a surgical or medical intervention that can jeopardize the completion of the trial
- Participation to other clinical trials, ongoing or terminated since less than 30 days before the beginning of the present experiment.
- Preceding randomization in this trial.
- Be component of the investigators' staff or be a relative of a member of the staff.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
No coadiuvant treatment.
The subject is treated with the antibiotic only and forbidden to take any coadiuvant medicine as a remedy for the symptoms during the period of the study.
|
|
Active Comparator: Saline solution
Saline solution sprayed according to the product indication.
Only one brand/specific product has been selected.
|
3 sprays per nostrils twice a day (morning and evening); in case of need a third nebulization between the two is allowed
Other Names:
|
Experimental: Sinuclean treatment
Sinuclean DM Spray.
|
3 sprays per nostrils twice a day (morning and evening); in case of need a third nebulization between the two is allowed
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Presence of Mucus in the Paranasal Sinuses (Outcome Measure Percentage of Patients)
Time Frame: After one week
|
Mucus detection in paranasal sinuses by clinical assessment(Outcome measure Percentage of patients)
|
After one week
|
Presence of Mucus in the Paranasal Sinuses (Outcome Measure Percentage of Patients)
Time Frame: After two weeks
|
Mucus detection in paranasal sinuses by clinical assessment(Outcome Measure Percentage of patients)
|
After two weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
FACIAL PAIN Daily Retrospective Ranking of Symptoms as Assessed by the Subject
Time Frame: After one week
|
Patient's daily diary retrospective ranked assessment of symptoms (0,1,2,3 with 0 = no symptoms; frequencies of patients with rank "0" were compared as outcome measure between groups
|
After one week
|
FACIAL PAIN Daily Retrospective Ranking of Symptoms as Assessed by the Subject
Time Frame: After two weeks
|
Patient's daily diary retrospective ranked assessment of symptoms (0,1,2,3 with 0 = no symptoms; frequencies of patients with rank "0" were compared as outcome measure between groups.
|
After two weeks
|
Recovery of Sinusitis Per Clinical Assessment(Outcome Measure Percentage of Patients)
Time Frame: After one week
|
Clinical assessment of healing of the sinusitis episode(Outcome Measure Percentage of patients healed).
Healing was assessed clinically by the physician as recovery of the condition prior to the diagnosis of the episode of sinusitis, without need of medical treatment.
|
After one week
|
Recovery of Sinusitis Per Clinical Assessment (Outcome Measure Percentage of Patients)
Time Frame: After two weeks
|
Clinical assessment of healing of the sinusitis episode (Outcome Measure Percentage of patients healed.
Healing was assessed clinically by the physician as recovery of the condition prior to the diagnosis of the episode of sinusitis, without need of medical treatment.
|
After two weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Gaetano Paludetti, MD, University Cattolica del Sacro Cuore Roma Italy
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GAL-01-2007
- EudraCT: 2007-003739-22 (Other Identifier: Sponsor Galsor srl)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sinusitis
-
Loma Linda UniversityWithdrawnChronic Sinus Disease | Chronic Sinusitis, Ethmoidal | Chronic Sinusitis, Sphenoidal | Chronic Sinusitis - Maxillary Bilateral | Chronic Sinusitis - Frontoethmoidal
-
LifeBridge HealthUnknownChronic Sinusitis | Nasal Polyps | Chronic Sinusitis, Ethmoidal | Chronic Sinusitis, Sphenoidal | Chronic Sinusitis - Frontoethmoidal | Chronic Sinusitis - Ethmoidal, Posterior | Chronic Sinusitis - Ethmoidal Anterior | Nasal Polyp - PosteriorUnited States
-
Tampere University HospitalRecruitingMaxillary Sinusitis | Eustachian Tube Dysfunction | Sinusitis, Chronic | Sinusitis RecurrentFinland
-
Collin County Ear Nose & ThroatIntersect ENTCompletedChronic Sinusitis, EthmoidalUnited States
-
STS MedicalNot yet recruitingChronic Sinusitis, Ethmoidal
-
St. Louis UniversityTerminatedStent | Sinusitis, FrontalUnited States
-
Oulu University HospitalTampere University HospitalRecruitingSinusitis | Maxillary Sinusitis | Sinusitis, AcuteFinland
-
Cairo UniversityNot yet recruitingChronic Maxillary Sinusitis
-
Centre Hospitalier Intercommunal CreteilActive, not recruitingChronic Maxillary SinusitisFrance
-
DeyCompletedACUTE SINUSITISUnited States
Clinical Trials on Saline solution
-
Chiang Mai UniversityCompletedPostoperative Nausea and Vomiting
-
Hospital Clinic of BarcelonaCompletedBronchiectasisSpain
-
Laval UniversityCanadian Institutes of Health Research (CIHR); Centre de Recheche du Centre...WithdrawnAcute Viral Bronchiolitis.Canada
-
Rabin Medical CenterUnknown
-
George Washington UniversityCompletedHysterectomy | MyomectomyUnited States
-
Federal University of Minas GeraisNot yet recruitingAnesthesia, ConductionBrazil
-
Assistance Publique - Hôpitaux de ParisCompletedAcute Viral BronchiolitisFrance
-
Children's Hospital of PhiladelphiaCompletedSaline Solution, Hypertonic | Bronchiolitis, ViralUnited States
-
Stefania La Grutta, MDCompleted
-
Contamac LtdAndre Vision and Device Research; The Contact Lens Center at Optique; Premiere... and other collaboratorsCompletedContact Lens Complication | Debris in Post Lens Tear ReservoirUnited States